Shire Laboratories, Inc.

Pharmavene, Inc.

George W Belendiuk

Edward M Rudnic

Beth A Burnside

Sandra E Wassink

John A McCarty

Richard Alan Couch

Charlotte M McGuinness

Carol E Mattes

The present invention relates to a composition and method of treating a patient by administering carbamazepine in a pharmaceutical dosage form capable of maintaining the patient's blood concentration at from about 4 .mu.g/ml to about 12 .mu.g/ml over at least a 12 hour period, where the blood concentration of carbamazepine does not vary by more than 60 percent.

Advanced drug delivery system and method of treating psychiatric,

A pharmaceutical preparation for oral acyclovir delivery comprising a stable, hydrophobic emulsion comprising continuous phase of a hydrophobic material selected from the group consisting of a long chain carboxylic acid or ester or alcohol thereof dispersed in an aqueous phase or (ii) having a hydrophilic discontinuous phase dispersed in a hydrophobic phase of a long chain carboxylic acid or alcohol thereof. The emulsion with acyclovir is incorporated into a pharmaceutical carrier suitable for oral delivery.

Oral acyclovir delivery

Growing community of inventors

Potomac, MD, United States of America

George W Belendiuk